FDA Drug Application (205382) for INCRUSE ELLIPTA by GLAXO GRP ENGLAND

Back to FDA Applications sponsored by GLAXO GRP ENGLAND

Application Number205382
Product Number001
FormPOWDER;INHALATION
DosageEQ 62.5MCG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINCRUSE ELLIPTA
Active IngredientUMECLIDINIUM BROMIDE

Active IngredientCount
List of drugs with Active Ingredient UMECLIDINIUM BROMIDE2


Back to FDA Applications sponsored by GLAXO GRP ENGLAND